ClinTec International expands US capabilities with the launch of New York office and senior Business Operations appointment
ClinTec International has unveiled a significant expansion into the US marketplace, with the launch of its New York office and the appointment of Susan Pavone, Associate Director of US Business Operations.
The expansion of US based operations through the launch of American headquarters, together with Susan Pavone’s appointment, will enable ClinTec to offer prospective US clients the chance to access global clinical research capabilities through a single partner. In the current economic climate, US life science and pharmaceutical companies are struggling to find medium sized global CROs capable of facilitating global clinical research needs. ClinTec has implemented a differentiated solution to mid-market competitors which combines all developed and emerging markets into a single global research platform.
President & CEO of ClinTec International, Dr Rabinder Buttar, commented: “We have established a strong presence in the international marketplace by placing expert clinical research staff in all key emerging, and established markets. The pharmaceutical industry is currently searching for new ways of working and delivering global solutions. ClinTec’s ability to harness global strength, coupled with local, on the ground expertise, will be of great value to US pharmaceutical companies. Our new Associate Director of (US) Operations, Susan Pavone, has extensive knowledge of international clinical research and the new US facilities will prove an invaluable asset to American companies looking to tap into our globalised resources and expertise. Susan has over two decades of industry experience, including eight years of successfully managing the business operations of Pfizer’s internal CRO, and her reputation for matching internal credibility and acceptance of solutions to client needs, is second to none.”
Most read news
Other news from the department business & finance

Get the life science industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.
More news from our other portals
Last viewed contents
Mount Sinai researchers develop tool to determine function of MicroRNAs
PAION agreement with Lundbeck comes into force, securing future Desmoteplase development and EUR 8 million upfront-payment
Epistem's Biomarker Division Gains GCLP Accreditation
Association for Professionals in Infection Control and Epidemiology, Inc. (APIC) - Washington, USA
Hereditary_nonpolyposis_colorectal_cancer
ClinTec’s CEO, Dr Rabinder Buttar wins the Institute of Directors, Director of the Year Award for Glasgow & West of Scotland
Rescue protein gives doomed cells a stay of 'execution'
Weill Cornell, Ithaca researchers use cotton candy to create new bloodflow routes

Discovery of a gene that causes chronic lymphocytic leukemia - CSIC researchers lead a study that shows that more than 82% of patients with this pathology have high levels of the RRAS2 gene.

Reverie Labs - Boston, USA
New model finds HIV acute phase infectivity may be lower than previously estimated
